N/A
N=87
Physical Activity and Neuropsychological Outcomes in a Cancer Population
Cognitive Dysfunction · Breast Cancer Survivors
Bottom Line
View on ClinicalTrials.gov: NCT02332876 ↗Enrolled (actual)
87
Serious AEs
0.0%
Results posted
Jul 2018
Primary outcome: Primary: National Institutes of Health Toolbox - Cognition Domain- Oral Symbol Digit Test — 7; 3 units on a scale — p=<0.05
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Exercise (Behavioral); Control (Behavioral)
- Age
- Adult, Older Adult · 21+ yrs
- Sex
- Female
- Sponsor
- University of California, San Diego
- Primary completion
- Jul 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY National Institutes of Health Toolbox - Cognition Domain- Oral Symbol Digit Test |
7; 3 | <0.05 sig |
Summary
Many cancer survivors experience treatment-related impairments in mental abilities such as memory, attention, and concentration (known as cognition). Research indicates that physical activity can improve cognition in healthy adults; however, little is known about whether physical activity can improve cognition among cancer survivors. This study will test whether a physical activity intervention results in improvements in cognition among breast cancer survivors, which may lead to interventions to improve cognition.
Eligibility Criteria
Inclusion Criteria
- breast cancer survivors; diagnosed at stage 1, 2, or 3 less than 5 years ago -
- not scheduled for or currently undergoing chemotherapy; sedentary, defined as engaging in less than 60 minutes of moderate to vigorous physical activity each week
- accessible geographically and by telephone
- have access to the internet
- endorse experience difficulties with thinking abilities
- in addition, participants on adjuvant therapy (e.g., tamoxifen or aromatase inhibitors) must be able and willing to remain on that treatment for the 3-month intervention period to prevent confounding of biomarker concentrations by treatment.
Exclusion Criteria
- history of coronary heart disease, diabetes, stroke, orthopedic conditions that limit mobility, or any other serious medical condition that could make it potentially unsafe to be in an unsupervised physical activity intervention
- other primary or recurrent invasive cancer within the last 10 years (other than nonmelanoma skin cancer or carcinoma of the cervix in situ)
- unable to commit to a 3-month intervention schedule; any condition that, in the investigators' judgment, would contraindicate increased physical activity or otherwise interfere with participation in the trial
- unable to provide a blood sample at the baseline measurement visit
- unable to speak and read English.
Data sourced from ClinicalTrials.gov (NCT02332876). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.